The proteome and gene expression profile of cementoblastic cells treated by bone morphogenetic protein-7 in vitro

被引:29
|
作者
Bozic, Darko [2 ]
Grgurevic, Lovorka [1 ]
Erjavec, Igor [1 ]
Brkljacic, Jelena [1 ]
Orlic, Iva [1 ]
Razdorov, Genadij [1 ]
Grgurevic, Ivica [3 ]
Vukicevic, Slobodan [1 ]
Plancak, Darije [2 ]
机构
[1] Univ Zagreb, Lab Mineralized Tissues, Sch Med, Ctr Translat & Clin Res, Zagreb 10000, Croatia
[2] Univ Zagreb, Sch Dent Med, Dept Periodontol, Zagreb 10000, Croatia
[3] Dubrava Univ Hosp, Dept Internal Med, Zagreb, Croatia
关键词
BMP1; BMP7; PCPE1; periodontal regeneration; proteomic analysis; tooth cementum; HUMAN OSTEOGENIC PROTEIN-1; ROOT SHEATH-CELLS; OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; GROWTH; IDENTIFICATION; MINERALIZATION; RECEPTORS; ROLES; REGENERATION;
D O I
10.1111/j.1600-051X.2011.01794.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Aim: Regenerative periodontal therapy is often unpredictable and limited. Cementum regeneration is necessary for the proper repair of a periodontal ligament. The precise mechanism how bone morphogenetic protein-7 (BMP7) induces differentiation and mineralization of cementoblasts remains undetermined. The purpose of this study was to evaluate the effect of BMP7 on early proteome and gene expression profile of cementoblastic OCCM. 30 cells in vitro. Materials and Methods: Immortalized murine cementoblasts (OCCM. 30) were exposed to BMP7 and evaluated for: (1) proliferation; (2) mineralization; (3) early proteome profile using liquid chromatography-mass spectrometry (LC-MS); and (4) gene expression by quantitative RT-PCR. Results: Bone morphogenetic protein-7 increased the cell proliferation at 24 h and 48 h, while higher doses suppressed the cell proliferation at 48 h. BMP7 induced the mineralization of cementoblasts following 8 days of therapy. Using LC-MS we identified 1117 proteins from the cell lysate. Many belonged to extracellular matrix formation such as PCPE1, collagens, annexins and integrin receptors. RT-PCR analyses revealed a BMP7 dose-dependent upregulation of BMP1, TGF beta 1, osterix, osteoprotegerin, procollagen I and II, PCPE1, and noggin, while BMP6 and chordin expression were decreased. The high BMP7 dose down regulated most of the genes 24 h following therapy. Conclusion: Bone morphogenetic protein-7 promotes differentiation and mineralization of cementoblasts via inducing PCPE1 and BMP1 responsible for processing of type I collagen.
引用
收藏
页码:80 / 90
页数:11
相关论文
共 50 条
  • [31] Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma
    G Fiaschetti
    D Castelletti
    S Zoller
    A Schramm
    C Schroeder
    M Nagaishi
    D Stearns
    M Mittelbronn
    A Eggert
    F Westermann
    H Ohgaki
    T Shalaby
    M Pruschy
    A Arcaro
    M A Grotzer
    Oncogene, 2011, 30 : 2823 - 2835
  • [32] A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7
    Dahabreh, Z.
    Calori, G. M.
    Kanakaris, N. K.
    Nikolaou, V. S.
    Giannoudis, P. V.
    INTERNATIONAL ORTHOPAEDICS, 2009, 33 (05) : 1407 - 1414
  • [33] Increased expression of bone morphogenetic protein-7 and its related pathway provides an anti-fibrotic effect on silica induced fibrosis in vitro
    Liang, Di
    Wang, Yan
    Zhu, Zhonghui
    Yang, Gengxia
    An, Guoliang
    Li, Xiaoli
    Niu, Piye
    Chen, Li
    Tian, Lin
    TOXICOLOGY RESEARCH, 2015, 4 (06) : 1511 - 1522
  • [34] Protective effect of bone morphogenetic protein-7 induced differentiation of bone marrow mesenchymal stem cells in rat with acute spinal cord injury
    Sun, Xudong
    Li, Maoyong
    Huang, Shiyuan
    Zhang, Heng
    Li, Kuanxin
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23 (01)
  • [35] An expedited approach for sustained delivery of bone morphogenetic protein-7 to bone defects using gene activated fragments of subcutaneous fat
    Betz, Volker M.
    Betz, Oliver B.
    Rosin, Tom
    Keller, Alexander
    Thirion, Christian
    Salomon, Michael
    Manthey, Suzanne
    Augat, Peter
    Jansson, Volkmar
    Mueller, Peter E.
    Rammelt, Stefan
    Zwipp, Hans
    JOURNAL OF GENE MEDICINE, 2016, 18 (08) : 199 - 207
  • [36] Bone morphogenetic protein-7 prevented epithelial-mesenchymal transition in RLE-6TN cells
    Wang, Yan
    Liang, Di
    Zhu, Zhonghui
    Li, Xiaoli
    An, Guoliang
    Niu, Piye
    Chen, Li
    Tian, Lin
    TOXICOLOGY RESEARCH, 2016, 5 (03) : 931 - 937
  • [37] Bone morphogenetic protein-7 and Gremlin: New emerging therapeutic targets for diabetic nephropathy
    Zhang, Yanling
    Zhang, Qingxian
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 383 (01) : 1 - 3
  • [38] Potential of bone morphogenetic protein-7 in treatment of lupus nephritis: addressing the hurdles to implementation
    Smith, Carine
    du Toit, Riette
    Ollewagen, Tracey
    INFLAMMOPHARMACOLOGY, 2023, 31 (05) : 2161 - 2172
  • [39] Development of optical immunosensors and their application to the analysis of human bone morphogenetic protein-7 (BMP-7)
    Kim, Chun-Kwang
    Rhee, Jong Il
    Sohn, Ok-Jae
    NANOSCALE IMAGING, SENSING, AND ACTUATION FOR BIOMEDICAL APPLICATIONS VII, 2011, 7908
  • [40] Recombinant Human Bone Morphogenetic Protein-7 Enhances Fracture Healing in an Ischemic Environment
    Lu, Chuanyong
    Xing, Zhiqing
    Yu, Yan-yiu
    Colnot, Celine
    Miclau, Theodore
    Marcucio, Ralph S.
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2010, 28 (05) : 687 - 696